Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2014 (2014), Article ID 154350, 5 pages
http://dx.doi.org/10.1155/2014/154350
Clinical Study

Facing Contrast-Enhancing Gliomas: Perfusion MRI in Grade III and Grade IV Gliomas according to Tumor Area

1Neuro-Oncology Unit, C. Mondino National Neurological Institute, 27100 Pavia, Italy
2Department of Brain and Behavioral Sciences, University of Pavia, 27100 Pavia, Italy
3Magnetic Resonance Laboratory, IRCCS Don Gnocchi Foundation, 20148 Milan, Italy
4Neuroscience Consortium, University of Pavia, Monza Policlinico and Pavia Mondino, 27100 Pavia, Italy
5Neuroradiological Department, C. Mondino National Neurological Institute, 27100 Pavia, Italy
6General Neurology Unit, C. Mondino National Neurological Institute, 27100 Pavia, Italy
7Department of Neuroradiology, IRCCS Foundation Neurological Institute C. Besta, 20133 Milan, Italy
8Department of Neurosurgery, IRCCS Neuromed, Pozzilli (IS), University of Rome La Sapienza, 00185 Rome, Italy
9Department of Neurosurgery, University of Messina, 98122 Messina, Italy

Received 14 February 2014; Accepted 6 March 2014; Published 3 April 2014

Academic Editor: Lombardi Giuseppe

Copyright © 2014 Anna Luisa Di Stefano et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. N. Louis, H. Ohgaki, O. D. Wiestler et al., “The 2007 WHO classification of tumours of the central nervous system,” Acta Neuropathologica, vol. 114, no. 2, pp. 97–109, 2007. View at Google Scholar · View at Scopus
  2. D. N. Louis, H. Ohgaki, O. D. Wiestler, and W. K. Cavenee, WHO Classification of Tumours of the Central Nervous System, IARC, Lyon , France, 2007.
  3. R. Felix, W. Schorner, and M. Laniado, “Brain tumors: MR imaging with gadolinium-DTPA,” Radiology, vol. 156, no. 3, pp. 681–688, 1985. View at Google Scholar · View at Scopus
  4. B. L. Dean, B. P. Drayer, C. R. Bird et al., “Gliomas: classification with MR imaging,” Radiology, vol. 174, no. 2, pp. 411–415, 1990. View at Google Scholar · View at Scopus
  5. J. R. Petrella and J. M. Provenzale, “MR perfusion imaging of the brain: techniques and applications,” American Journal of Roentgenology, vol. 175, no. 1, pp. 207–219, 2000. View at Google Scholar · View at Scopus
  6. T. Sugahara, Y. Korogi, M. Kochi et al., “Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas,” American Journal of Roentgenology, vol. 171, no. 6, pp. 1479–1486, 1998. View at Google Scholar · View at Scopus
  7. H. J. Aronen, F. S. Pardo, D. N. Kennedy et al., “High microvascular blood volume is associated with high glucose uptake and tumor angiogenesis in human gliomas,” Clinical Cancer Research, vol. 6, no. 6, pp. 2189–2200, 2000. View at Google Scholar · View at Scopus
  8. E. A. Knopp, S. Cha, G. Johnson et al., “Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging,” Radiology, vol. 211, no. 3, pp. 791–798, 1999. View at Google Scholar · View at Scopus
  9. N. Fayed, J. Dávila, J. Medrano, and S. Olmos, “Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI,” European Journal of Radiology, vol. 67, no. 3, pp. 427–433, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. S. Cha, E. A. Knopp, G. Johnson, S. G. Wetzel, A. W. Litt, and D. Zagzag, “Intracranial mass lesions: dynamic contrast-enhanced susceptibility-weighted echo-planar perfusion MR imaging,” Radiology, vol. 223, no. 1, pp. 11–29, 2002. View at Google Scholar · View at Scopus
  11. R. Sanz-Requena, A. Revert-Ventura, L. Martí-Bonmatí, Á. Alberich-Bayarri, and G. García-Martí, “Quantitative MR perfusion parameters related to survival time in high-grade gliomas,” European Radiology, vol. 23, no. 12, pp. 3456–3465, 2013. View at Publisher · View at Google Scholar
  12. S. Blasel, K. Franz, M. Mittelbronn et al., “The striate sign: peritumoural perfusion pattern of infiltrative primary and recurrent gliomas,” Neurosurgical Review, vol. 33, no. 2, pp. 193–203, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Blasel, K. Franz, H. Ackermann, S. Weidauer, F. Zanella, and E. Hattingen, “Stripe-like increase of rCBV beyond the visible border of glioblastomas: site of tumor infiltration growing after neurosurgery,” Journal of Neuro-Oncology, vol. 103, no. 3, pp. 575–584, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. J. L. Boxerman, K. M. Schmainda, and R. M. Weisskoff, “Relative cerebral blood volume maps corrected for contrast agent extravasation significantly correlate with glioma tumor grade, whereas uncorrected maps do not,” American Journal of Neuroradiology, vol. 27, no. 4, pp. 859–867, 2006. View at Google Scholar · View at Scopus
  15. M. Law, R. J. Young, J. S. Babb et al., “Gliomas: predicting time to progression or survival with cerebral blood volume measurements at dynamic susceptibility-weighted contrast-enhanced perfusion MR imaging,” Radiology, vol. 247, no. 2, pp. 490–498, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. B. R. Rosen, J. W. Belliveau, J. M. Vevea, and T. J. Brady, “Perfusion imaging with NMR contrast agents,” Magnetic Resonance in Medicine, vol. 14, no. 2, pp. 249–265, 1990. View at Publisher · View at Google Scholar · View at Scopus
  17. I. C. Chiang, Y. T. Kuo, C. Y. Lu et al., “Distinction betweenhigh-grade gliomas and solitary metastases using peritumoral 3-T magnetic resonance spectroscopy, diffusion, and perfusion imagings,” Neuroradiology, vol. 46, no. 8, pp. 619–627, 2004. View at Google Scholar
  18. P. J. Kelly, C. Daumas-Duport, and D. B. Kispert, “Imaging-based stereotaxic serial biopsies in untreated intracranial glial neoplasms,” Journal of Neurosurgery, vol. 66, no. 6, pp. 865–874, 1987. View at Google Scholar · View at Scopus